Association analyses identify 31 new risk loci for colorectal cancer susceptibility
- PMID: 31089142
- PMCID: PMC6517433
- DOI: 10.1038/s41467-019-09775-w
Association analyses identify 31 new risk loci for colorectal cancer susceptibility
Abstract
Colorectal cancer (CRC) is a leading cause of cancer-related death worldwide, and has a strong heritable basis. We report a genome-wide association analysis of 34,627 CRC cases and 71,379 controls of European ancestry that identifies SNPs at 31 new CRC risk loci. We also identify eight independent risk SNPs at the new and previously reported European CRC loci, and a further nine CRC SNPs at loci previously only identified in Asian populations. We use in situ promoter capture Hi-C (CHi-C), gene expression, and in silico annotation methods to identify likely target genes of CRC SNPs. Whilst these new SNP associations implicate target genes that are enriched for known CRC pathways such as Wnt and BMP, they also highlight novel pathways with no prior links to colorectal tumourigenesis. These findings provide further insight into CRC susceptibility and enhance the prospects of applying genetic risk scores to personalised screening and prevention.
Conflict of interest statement
D.K. is a founder and shareholder of Oxford Cancer Biomarkers. V.S. has participated in a conference trip sponsored by Novo Nordisk and received an honorarium from the same source for participating in an advisory board meeting. The remaining authors declare no competing interests.
Figures



References
Publication types
MeSH terms
Grants and funding
- 22804/CRUK_/Cancer Research UK/United Kingdom
- MC_PC_U127527198/MRC_/Medical Research Council/United Kingdom
- MC_UU_12023/20/MRC_/Medical Research Council/United Kingdom
- 12076/CRUK_/Cancer Research UK/United Kingdom
- U01 CA188392/CA/NCI NIH HHS/United States
- MC_U122861325/MRC_/Medical Research Council/United Kingdom
- MR/K026992/1/MRC_/Medical Research Council/United Kingdom
- U01 CA167551/CA/NCI NIH HHS/United States
- 18927/CRUK_/Cancer Research UK/United Kingdom
- K02 AA018755/AA/NIAAA NIH HHS/United States
- R01 AA012502/AA/NIAAA NIH HHS/United States
- U01 CA122839/CA/NCI NIH HHS/United States
- 27327/CRUK_/Cancer Research UK/United Kingdom
- MR/M012190/1/MRC_/Medical Research Council/United Kingdom
- MC_UU_00007/10/MRC_/Medical Research Council/United Kingdom
- MC_UU_00007/1/MRC_/Medical Research Council/United Kingdom
- MR/P001106/1/MRC_/Medical Research Council/United Kingdom
- 18504/CRUK_/Cancer Research UK/United Kingdom
- 25355/CRUK_/Cancer Research UK/United Kingdom
- MR/N01104X/2/MRC_/Medical Research Council/United Kingdom
- MR/N003284/1/MRC_/Medical Research Council/United Kingdom
- MR/M004007/1/MRC_/Medical Research Council/United Kingdom
- G1000143/MRC_/Medical Research Council/United Kingdom
- U24 CA074794/CA/NCI NIH HHS/United States
- HHSN268201200008C/HL/NHLBI NIH HHS/United States
- MC_U127527198/MRC_/Medical Research Council/United Kingdom
- U01 CA074794/CA/NCI NIH HHS/United States
- 14136/CRUK_/Cancer Research UK/United Kingdom
- U19 CA148537/CA/NCI NIH HHS/United States
- R01 CA143237/CA/NCI NIH HHS/United States
- G0401527/MRC_/Medical Research Council/United Kingdom
- MR/K018647/1/MRC_/Medical Research Council/United Kingdom
- MR/M016587/1/MRC_/Medical Research Council/United Kingdom
- MC_UU_12023/3/MRC_/Medical Research Council/United Kingdom
- 16563/CRUK_/Cancer Research UK/United Kingdom
- K05 AA000145/AA/NIAAA NIH HHS/United States
- S10 OD020069/OD/NIH HHS/United States
- 10119/CRUK_/Cancer Research UK/United Kingdom
- WT_/Wellcome Trust/United Kingdom
- 10118/CRUK_/Cancer Research UK/United Kingdom
- G0600237/MRC_/Medical Research Council/United Kingdom
- HHSN268201200008I/HL/NHLBI NIH HHS/United States
- 25514/CRUK_/Cancer Research UK/United Kingdom
- 16561/CRUK_/Cancer Research UK/United Kingdom
- G0600329/MRC_/Medical Research Council/United Kingdom
- 10124/CRUK_/Cancer Research UK/United Kingdom
- R37 AA012502/AA/NIAAA NIH HHS/United States
LinkOut - more resources
Full Text Sources
Medical